Asan Medical Center: Colorectal Neoplasms trials

The registry lists 11 Colorectal Neoplasms studies with Asan Medical Center as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 2 6Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal CancerCompletedNCT03435107Phase 2Results posted
• [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to RegorafenibCompletedNCT02175095Not applicableResults posted
• Treatment of Colorectal Liver Metastases With Immunotherapy and BevacizumabCompletedNCT03698461Phase 2
• Avelumab for MSI-H or POLE Mutated Metastatic Colorectal CancerStatus unknownNCT03150706Phase 2
• Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal NeoplasmStatus unknownNCT01944540Not applicable
• Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic BubblesCompletedNCT01790139Not applicable
• Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus FluoropyrimidinesWithdrawnNCT01786538Phase 3
• Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal CancerStatus unknownNCT01428752
• Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)CompletedNCT00862342Phase 2
• Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsCompletedNCT00637091Phase 2
• Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon CancerCompletedNCT00378066Phase 2